Logo image of ZEN

ZENDESK INC (ZEN) Stock Fundamental Analysis

NYSE:ZEN - New York Stock Exchange, Inc. - US98936J1016 - Common Stock - Currency: USD

77.48  +0.02 (+0.03%)

After market: 77.47 -0.01 (-0.01%)

Fundamental Rating

3

Overall ZEN gets a fundamental rating of 3 out of 10. We evaluated ZEN against 281 industry peers in the Software industry. ZEN has a bad profitability rating. Also its financial health evaluation is rather negative. ZEN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ZEN was profitable.
ZEN had a positive operating cash flow in the past year.
ZEN Yearly Net Income VS EBIT VS OCF VS FCFZEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -11.43%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZEN Yearly ROA, ROE, ROICZEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 -10 -20 -30 -40 -50

1.3 Margins

Industry RankSector Rank
OM -11.94%
PM (TTM) -17.82%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN Yearly Profit, Operating, Gross MarginsZEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZEN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ZEN has been reduced compared to a year ago.
ZEN Yearly Shares OutstandingZEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
ZEN Yearly Total Debt VS Total AssetsZEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.49 indicates that ZEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of ZEN is 13.52, which is on the high side as it means it would take ZEN, 13.52 years of fcf income to pay off all of its debts.
ZEN has a Debt/Equity ratio of 3.28. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 3.28
Debt/FCF 13.52
Altman-Z 2.49
ROIC/WACCN/A
WACC10.26%
ZEN Yearly LT Debt VS Equity VS FCFZEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.83 indicates that ZEN should not have too much problems paying its short term obligations.
A Quick Ratio of 1.83 indicates that ZEN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
ZEN Yearly Current Assets VS Current LiabilitesZEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B

More info and screens

9

3. Growth

3.1 Past

ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.59%, which is quite impressive.
Measured over the past years, ZEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 37.95% on average per year.
The Revenue has grown by 27.36% in the past year. This is a very strong growth!
Measured over the past years, ZEN shows a very strong growth in Revenue. The Revenue has been growing by 33.74% on average per year.
EPS 1Y (TTM)27.59%
EPS 3Y37.95%
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)27.36%
Revenue growth 3Y30.76%
Revenue growth 5Y33.74%
Sales Q2Q%20.14%

3.2 Future

ZEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.24% yearly.
ZEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.27% yearly.
EPS Next Y19.22%
EPS Next 2Y21.55%
EPS Next 3Y33.11%
EPS Next 5Y36.24%
Revenue Next Year24.81%
Revenue Next 2Y20.95%
Revenue Next 3Y19.62%
Revenue Next 5Y15.27%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZEN Yearly Revenue VS EstimatesZEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
ZEN Yearly EPS VS EstimatesZEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 104.70, which means the current valuation is very expensive for ZEN.
ZEN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.22.
With a Price/Forward Earnings ratio of 83.24, ZEN can be considered very expensive at the moment.
ZEN is valuated expensively when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 104.7
Fwd PE 83.24
ZEN Price Earnings VS Forward Price EarningsZEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF 91.29
EV/EBITDA -50.13
ZEN Per share dataZEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZEN does not grow enough to justify the current Price/Earnings ratio.
ZEN's earnings are expected to grow with 33.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.45
PEG (5Y)N/A
EPS Next 2Y21.55%
EPS Next 3Y33.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENDESK INC

NYSE:ZEN (11/21/2022, 8:14:42 PM)

After market: 77.47 -0.01 (-0.01%)

77.48

+0.02 (+0.03%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-27 2022-10-27/amc
Earnings (Next)02-08 2023-02-08
Inst Owners0%
Inst Owner Change0%
Ins Owners0.5%
Ins Owner Change0%
Market Cap8.69B
Analysts65.26
Price Target95.06 (22.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.98%
Min EPS beat(2)13.37%
Max EPS beat(2)42.59%
EPS beat(4)2
Avg EPS beat(4)6.12%
Min EPS beat(4)-18.13%
Max EPS beat(4)42.59%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.77%
Min Revenue beat(2)-3.21%
Max Revenue beat(2)-0.34%
Revenue beat(4)1
Avg Revenue beat(4)-0.77%
Min Revenue beat(4)-3.21%
Max Revenue beat(4)0.49%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)-5.32%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-1.55%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 104.7
Fwd PE 83.24
P/S 5.47
P/FCF 91.29
P/OCF 69.17
P/B 25.06
P/tB 61.9
EV/EBITDA -50.13
EPS(TTM)0.74
EY0.96%
EPS(NY)0.93
Fwd EY1.2%
FCF(TTM)0.85
FCFY1.1%
OCF(TTM)1.12
OCFY1.45%
SpS14.15
BVpS3.09
TBVpS1.25
PEG (NY)5.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.43%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -11.94%
PM (TTM) -17.82%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 3.28
Debt/FCF 13.52
Debt/EBITDA N/A
Cap/Depr 79.32%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 2.49
F-Score5
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)96.73%
Cap/Depr(5y)96.2%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.59%
EPS 3Y37.95%
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y19.22%
EPS Next 2Y21.55%
EPS Next 3Y33.11%
EPS Next 5Y36.24%
Revenue 1Y (TTM)27.36%
Revenue growth 3Y30.76%
Revenue growth 5Y33.74%
Sales Q2Q%20.14%
Revenue Next Year24.81%
Revenue Next 2Y20.95%
Revenue Next 3Y19.62%
Revenue Next 5Y15.27%
EBIT growth 1Y-22.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year69.87%
EBIT Next 3Y51.4%
EBIT Next 5Y39.49%
FCF growth 1Y376.36%
FCF growth 3Y57.09%
FCF growth 5YN/A
OCF growth 1Y923.24%
OCF growth 3Y29.25%
OCF growth 5Y47.21%